Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 55% ± 17% | |
endothelial cell | 12 studies | 27% ± 15% | |
glutamatergic neuron | 12 studies | 42% ± 24% | |
oligodendrocyte precursor cell | 10 studies | 37% ± 14% | |
macrophage | 9 studies | 26% ± 9% | |
GABAergic neuron | 8 studies | 52% ± 21% | |
astrocyte | 6 studies | 26% ± 4% | |
interneuron | 6 studies | 54% ± 20% | |
neuron | 5 studies | 39% ± 16% | |
ciliated cell | 5 studies | 21% ± 4% | |
endothelial cell of lymphatic vessel | 5 studies | 29% ± 5% | |
monocyte | 5 studies | 21% ± 8% | |
microglial cell | 4 studies | 28% ± 9% | |
myeloid cell | 4 studies | 33% ± 14% | |
GABAergic interneuron | 3 studies | 46% ± 11% | |
granule cell | 3 studies | 39% ± 14% | |
alveolar macrophage | 3 studies | 36% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 42% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4635.85 | 2638 / 2642 | 100% | 14.16 | 704 / 705 |
esophagus | 99% | 1628.86 | 1425 / 1445 | 92% | 3.59 | 169 / 183 |
kidney | 99% | 1040.84 | 88 / 89 | 88% | 3.57 | 791 / 901 |
uterus | 100% | 2828.23 | 170 / 170 | 84% | 3.96 | 384 / 459 |
breast | 100% | 1419.70 | 458 / 459 | 84% | 2.62 | 935 / 1118 |
lung | 100% | 1989.67 | 578 / 578 | 81% | 2.47 | 933 / 1155 |
ovary | 100% | 2363.94 | 180 / 180 | 79% | 2.52 | 340 / 430 |
adrenal gland | 86% | 629.88 | 223 / 258 | 92% | 5.76 | 211 / 230 |
bladder | 100% | 992.19 | 21 / 21 | 66% | 2.16 | 332 / 504 |
intestine | 95% | 1577.64 | 919 / 966 | 64% | 1.75 | 336 / 527 |
prostate | 99% | 1326.33 | 243 / 245 | 52% | 0.88 | 261 / 502 |
thymus | 100% | 1495.60 | 651 / 653 | 47% | 1.49 | 287 / 605 |
pancreas | 53% | 323.31 | 174 / 328 | 93% | 3.90 | 166 / 178 |
skin | 83% | 842.74 | 1509 / 1809 | 47% | 1.47 | 223 / 472 |
stomach | 61% | 581.52 | 219 / 359 | 63% | 1.48 | 181 / 286 |
spleen | 100% | 1693.66 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1457.20 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1226.84 | 1315 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 798.98 | 774 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 1.75 | 31 / 45 |
heart | 64% | 399.22 | 550 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 0.87 | 14 / 29 |
liver | 5% | 27.59 | 12 / 226 | 33% | 0.88 | 133 / 406 |
eye | 0% | 0 | 0 / 0 | 34% | 0.64 | 27 / 80 |
muscle | 6% | 28.12 | 48 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_0016024 | Biological process | CDP-diacylglycerol biosynthetic process |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0012505 | Cellular component | endomembrane system |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003841 | Molecular function | 1-acylglycerol-3-phosphate O-acyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AGPAT4 |
Protein name | AGPAT4 protein 1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta) 1-acylglycerol-3-phosphate O-acyltransferase (EC 2.3.1.51) 1-acylglycerol-3-phosphate O-acyltransferase 4 |
Synonyms | UNQ499/PRO1016 hCG_1781301 DKFZp686G10113 |
Description | FUNCTION: Converts 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone (By similarity). Exhibits high acyl-CoA specificity for polyunsaturated fatty acyl-CoA, especially docosahexaenoyl-CoA (22:6-CoA, DHA-CoA) (By similarity). . |
Accessions | ENST00000366911.9 Q9NRZ5 ENST00000437165.1 Q6PJN9 Q6AI25 ENST00000436279.1 B4DHC0 ENST00000320285.9 [Q9NRZ5-1] ENST00000366905.3 G3XAF1 Q5TEE8 H0Y5R3 |